Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline. Yilmaz E, Ismaila N, Bauman JE, Dabney R, et al. J Clin Oncol 2022 Dec 15:JCO2202328. doi: 10.1200/JCO.22.02328.

Read + Share

Amedeo Smart

Independent Medical Education

Yilmaz E, Ismaila N, Bauman JE, Dabney R, et al. Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline. J Clin Oncol 2022 Dec 15:JCO2202328. doi: 10.1200/JCO.22.02328.
PMID: 36521102